AST-1306
CAS No. 1050500-29-2
AST-1306 ( —— )
Catalog No. M10245 CAS No. 1050500-29-2
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 110 | In Stock |
|
10MG | 177 | In Stock |
|
25MG | 335 | In Stock |
|
50MG | 500 | In Stock |
|
100MG | 705 | In Stock |
|
500MG | 1485 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAST-1306
-
NoteResearch use only, not for human use.
-
Brief DescriptionAST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R.
-
DescriptionAST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R, more potent to ErbB2-overexpressing cells, 3000-fold selective for ErbB family than other kinases,
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR; EGFR (T790M/L858R); HER2/ErbB2; HER2/ErbB2; FLT1
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1050500-29-2
-
Formula Weight621.08
-
Molecular FormulaC31H26ClFN4O5S
-
Purity>98%(HPLC)
-
SolubilityDMSO:124 mg/mL (199.65 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
-
SMILESCC1=CC=C(C=C1)S(O)(=O)=O.FC1=CC(COC2=CC=C(NC3=C4C=C(NC(=O)C=C)C=CC4=NC=N3)C=C2Cl)=CC=C1 |c:3,5,22,31,34,36,39,42,44,t:1,12,17,19,24|
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xie H, et al. PLoS One. 2011, 6(7), e21487.
molnova catalog
related products
-
Icotinib
Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM.
-
Alflutinib
Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.
-
WHI-P258
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.